Loading...
Based on the provided data, DuPont De Nemours Inc (DD) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the stock has some positive catalysts like bullish analyst ratings and price target increases, the technical indicators are mixed, and the financial performance shows a net loss with minimal revenue growth. Additionally, there are no strong proprietary trading signals or significant recent events to suggest immediate upside potential.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 55.211, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 49.242, and resistance is at 52.115. The stock is trading below the pivot point of 50.679, suggesting a weak price trend.

Analyst ratings are overwhelmingly positive, with multiple firms raising price targets to $52-$60 and maintaining Buy/Outperform ratings. Analysts cite EPS growth potential, margin improvements, and exposure to strong sectors like Water and Healthcare as key drivers.
The company's financial performance is weak, with a net loss of $126 million in Q4 2025 and flat revenue growth. The MACD and recent price trend suggest bearish momentum. Additionally, there are no significant hedge fund or insider trading trends to support a strong buy case.
In Q4 2025, revenue growth was flat (0.00% YoY), and net income was negative at -$126 million, though it improved 5.88% YoY. EPS increased slightly to -0.3 (up 7.14% YoY), and gross margin improved to 30.25% (up 4.17% YoY). Overall, financials show slight improvements but remain weak.
Analysts are bullish, with multiple firms raising price targets to $52-$60. Deutsche Bank, JPMorgan, Citi, and others maintain Buy/Outperform ratings, citing strong growth potential and margin improvements. However, UBS slightly lowered its price target to $56 from $59, reflecting some caution.